General
Showing 513–528 of 736 results
-
Article: O.10 THE DEUBIQUITINASE USP13 AS A NOVEL THERAPEUTIC CO-TARGET IN EGFR MUTANT NON-SMALL CELL LUNG CANCER
€2.50 Add to cart -
Article: O.10 USP13 as a novel co-target for EGFR targeted therapies in EGFR mutant non-small cell lung cancer
€2.50 Add to cart -
Article: Oligometastatic ovarian cancer successfully treated with stereotactic radiotherapy
€2.50 Add to cart -
Article: Oncological topics presented at EAU 2018
€2.50 Add to cart -
Article: Operational Risk Management (ORM): the aviation safety model can be transposed into the medical sector
€2.50 Add to cart -
Article: Opportunities and challenges in oncology and molecular testing: the Belgian strategy
€2.50 Add to cart -
Article: Optimal management of pancreatic cancer: current standards and challenges for improving care and research
€2.50 Add to cart -
Article: Optimising target volume definition and treatment accuracy in oesophageal cancer
€2.50 Add to cart -
Article: Overview of trials running in the Benelux
€2.50 Add to cart -
Article: Overview of trials running in the Benelux
€2.50 Add to cart -
Article: Overview of trials running in the Benelux
€2.50 Add to cart -
Article: Overview of trials running in the Benelux
€2.50 Add to cart -
Article: Overview of trials running in the Benelux
€2.50 Add to cart -
Article: P.01 A LUNG CANCER-DERIVED CRAF MUTATION IS ERK PATHWAY ACTIVATING AND PREDICTS SENSITIVITY TO COMBINED TYPE II RAF AND MEK INHIBITION
€2.50 Add to cart -
Article: P.01 Targeting Polo-like kinase 1 and TRAIL enhances apoptosis in non-small cell lung cancer (NSCLC) cells
€2.50 Add to cart -
Article: P.02 Polymorphisms in the Von Hippel Lindau gene are associated with poor overall survival in metastatic clear-cell renal cell carcinoma patients treated with VEGFR tyrosine kinase inhibitors
€2.50 Add to cart
